Biography
Shannon Clark is a patent litigator who focuses on cases involving chemicals, pharmaceuticals, and biotechnology, and has extensive experience litigating Abbreviated New Drug Application (ANDA) cases brought under the Hatch-Waxman Act. She has litigated patent disputes from inception through trial, including as lead trial counsel.
She previously served as a judicial law clerk to the Honorable Garrett E. Brown, Jr., U.S.D.J., and the Honorable Joel A. Pisano, U.S.D.J., in the U.S. District Court for the District of New Jersey.
Shannon’s notable cases include:
- Represented Novartis in Novartis v. Breckenridge, West-Ward, and Par (Zortress® (everolimus) for kidney and liver transplantation); Novartis v. West-Ward (Afinitor® (everolimus) for renal cell carcinoma and pancreatic neuroendocrine tumors); Novartis v. Par (Afinitor® (everolimus) for breast cancer)
- Represented Regeneron in Regeneron v. Merus (VelocImmune® transgenic mice)
- Represented Bausch Health in Bausch Health v. Sun (Xifaxan® (rifaximin) for travelers’ diarrhea); Bausch Health v. Sandoz (Xifaxan® (rifaximin) to treat irritable bowel syndrome with diarrhea); Valeant v. Actavis (Xifaxan® (rifaximin) to treat irritable bowel syndrome with diarrhea and hepatic encephalopathy)
- Represented UCB in UCB v. Mallinckrodt and UCB v. Teva (Metadate® CD (methylphenidate) for attention deficit hyperactivity disorder)
Education
Birmingham-Southern College, B.S., Biology, cum laude
Seton Hall University, J.D., magna cum laude and Order of the Coif
Admissions
- New York
- Virginia
- U.S. Patent and Trademark Office
- U.S. Court of Appeals, Federal Circuit